Improving Retail Access to Naloxone
Register today to join us!
Featuring

[Moderator] Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute

Katharine Neill Harris, Ph.D., Alfred C. Glassell, III, Fellow in Drug Policy, Rice University’s Baker Institute for Public Policy

Marianne Gibson, Program Director, Health, National Governors Association’s Center for Best Practices

Brigid K Groves, PharmD, Vice President, Professional Affairs, American Pharmacists Association
Overview
Although fatalities have declined in recent years, drug overdose remains a top cause of preventable death in the United States. Naloxone is a safe, effective medication that reverses opioid overdoses and restores breathing within minutes. However, for this lifesaving tool to have population-level impact, people who use drugs—as well as their friends and loved ones and our communities at large—must have consistent, low-barrier access to affordable doses. While syringe services programs are the primary distributors of free and low-cost naloxone, pharmacies can fill availability gaps due to their extended hours and geographic ubiquity.
Join us for a virtual panel discussion on overcoming challenges in the retail naloxone market.